Mesalamine and Hyrimoz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mesalamine (mesalamine) and Hyrimoz (adalimumab-adaz). Common drug interactions include malaise among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mesalamine and Hyrimoz. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

What is Hyrimoz?

Hyrimoz has active ingredients of adalimumab-adaz. eHealthMe is studying from 4,635 Hyrimoz users. Check the latest studies of Hyrimoz.

On Jul, 08, 2026

37 people who take Mesalamine and Hyrimoz together, and have interactions are studied.

Mesalamine and Hyrimoz drug interactions.

What are the common drug interactions of Mesalamine and Hyrimoz, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Abdominal pain
Drug ineffective
Diarrhoea haemorrhagic (bloody diarrhoea)
Therapeutic response decreased (less preventive response)
Constipation
Haematochezia (passage of stools containing blood)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Rectal haemorrhage (bleeding from anus)
Erythema (redness of the skin)

male:

Asthenia (weakness)
Cough
Anxiety
Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Secretion discharge
Arthralgia (joint pain)
Intestinal adenocarcinoma (intestinal cancer)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Pain in extremity

What are the common drug interactions of Mesalamine and Hyrimoz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Asthenia (weakness)
Cough
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nasopharyngitis (inflammation of the nasopharynx)
Pyrexia (fever)
Sinusitis (inflammation of sinus)

30-39:

Abdominal discomfort
Abdominal distension
Abdominal pain
Arthralgia (joint pain)
Bowel movement irregularity
Diarrhoea
Dyspepsia (indigestion)
Fatigue (feeling of tiredness)
Lactose intolerance (inability to digest lactose)
Pyrexia (fever)

40-49:

Anxiety
Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Secretion discharge

50-59:

Ankylosing spondylitis (type of arthritis affecting the spine)
Breast cancer
Injection site erythema (redness at injection site)
Injection site pain
Injection site pruritus (severe itching at injection site)
Malaise (a feeling of general discomfort or uneasiness)
Oropharyngeal pain
Pain
Pneumonia
Arthralgia (joint pain)

60+:

Abdominal pain
Drug ineffective
Dyspepsia (indigestion)
Erythema (redness of the skin)
Female genital tract fistula (passage in genital tract of female)
Frequent bowel movements
Headache (pain in head)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Nausea (feeling of having an urge to vomit)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 20 people, 54.05%
Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 18.92%
Allergies: 4 people, 10.81%

* Approximation only. Some reports may have incomplete information.

Do you take Mesalamine and Hyrimoz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously